<p>Aprea Therapeutics Inc. has announced a $3.1 million private placement, selling 2,623,023 shares of common stock (or pre-funded warrants) along with warrants to purchase an equal number of shares. The offering is priced at-the-market under Nasdaq rules, with each share and accompanying warrant sold at a combined price of $1.165 and the warrants exercisable at $1.04 per share. The securities are being offered in a private placement and are not registered under the Securities Act. Proceeds from the sale are expected to extend the company’s cash runway into the first quarter of 2027 and will be used for general corporate and research and development purposes. Maxim Group LLC is serving as the sole placement agent for the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprea Therapeutics Inc. published the original content used to generate this news brief on December 09, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

APRE

<p>Aprea Therapeutics Inc. announced a $3.1 million private placement, selling shares and warrants at $1.165 each, exercisable at $1.04 per share. Proceeds will extend cash runway to Q1 2027 for corporate and R&D purposes. Maxim Group LLC is the sole placement agent. The securities are offered privately and are not registered under the Securities Act.</p>

Aprea Therapeutics Raises $3.1 Million in Private Placement